z-logo
open-access-imgOpen Access
PHARMACOGENOMIC CONSIDERATIONS FOR PRESCRIBING THE ANTIDEPRESSANT FLUOXETINE: A REVIEW IN PERSONALIZED MEDICINE
Author(s) -
Isaac Karimi,
Nima Yakhchalian,
Mazyar Fathi,
Shahram Miraghaee
Publication year - 2022
Publication title -
universal journal of pharmaceutical research
Language(s) - English
Resource type - Journals
ISSN - 2456-8058
DOI - 10.22270/ujpr.v7i3.779
Subject(s) - pharmacogenomics , context (archaeology) , psychiatry , antidepressant , personalized medicine , fluoxetine , medicine , anxiety , major depressive disorder , pharmacotherapy , clinical psychology , psychology , intensive care medicine , bioinformatics , mood , pharmacology , serotonin , biology , paleontology , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom